Publication | Closed Access
Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer.
37
Citations
0
References
1998
Year
Iodine-123-VIP receptor scanning has the potential to offer additional information to augment diagnostic standard methods and could influence the decision-making process in the treatment of pancreatic cancer.